24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cancer Treatment
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:14
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
19:40
Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems
19:09
Intel VP: “We’re just not going to accept subpar products”
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
3
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
4
Check Point raises $1.75 billion, potentially eyeing AI expansion
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
Cancer Treatment
4 stories about Cancer Treatment
Vessi Medical completes $1.7 million in funding for minimally invasive bladder cancer treatment
01.09.20
|
CTech
The company aims to conduct the first human trials of its cold therapy treatment at the beginning of 2021
Ayala Pharmaceuticals Headed for Nasdaq IPO
07.01.20
|
Golan Hazani
The Israel-based cancer treatment developer wants to raise $100 million according to a $400 million company valuation
Pi Therapeutics Raises $19.7 Million
29.05.19
|
Hagar Ravet
Pi Therapeutics develops novel modulators of protein degradation for the treatment of cancer
Japanese NanoCarrier Partners with Cancer Treatment Company VBL Therapeutics
07.11.17
|
Dror Reich
The companies signed an exclusive licensing agreement in Japan for VBL's anti-cancer drug